Ignatoski KM - Search Results

1

Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.

Escara-Wilke J, Keller JM, Ignatoski KM, Dai J, Shelley G, Mizokami A, Zhang J, Yeung ML, Yeung KC, Keller ET. Escara-Wilke J, et al. Among authors: ignatoski km. Prostate. 2015 Feb 15;75(3):292-302. doi: 10.1002/pros.22915. Epub 2014 Oct 18. Prostate. 2015. PMID: 25327941 Free article.

2

RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model.

Ignatoski KM, Escara-Wilke JF, Dai JL, Lui A, Dougall W, Daignault S, Yao Z, Zhang J, Day ML, Sargent EE, Keller ET. Ignatoski KM, et al. Prostate. 2008 Jun 1;68(8):820-9. doi: 10.1002/pros.20744. Prostate. 2008. PMID: 18324676 Free PMC article.

3

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.

DeHaan AM, Wolters NM, Keller ET, Ignatoski KM. DeHaan AM, et al. Among authors: ignatoski km. Prostate. 2009 Apr 1;69(5):528-37. doi: 10.1002/pros.20903. Prostate. 2009. PMID: 19143022 Free PMC article.

4

Why should we still care about oncogenes?

Diehl KM, Keller ET, Ignatoski KM. Diehl KM, et al. Among authors: ignatoski km. Mol Cancer Ther. 2007 Feb;6(2):418-27. doi: 10.1158/1535-7163.MCT-06-0603. Mol Cancer Ther. 2007. PMID: 17308043 Review.

5

Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.

Ignatoski KM, Friedman J, Escara-Wilke J, Zhang X, Daignault S, Dunn RL, Smith DC, Keller ET. Ignatoski KM, et al. J Interferon Cytokine Res. 2009 Feb;29(2):105-12. doi: 10.1089/jir.2008.0024. J Interferon Cytokine Res. 2009. PMID: 19014338 Free PMC article. Clinical Trial.

6

Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model.

Sueyoshi R, Ignatoski KM, Daignault S, Okawada M, Teitelbaum DH. Sueyoshi R, et al. Among authors: ignatoski km. Dig Dis Sci. 2013 Nov;58(11):3165-77. doi: 10.1007/s10620-013-2825-4. Epub 2013 Aug 15. Dig Dis Sci. 2013. PMID: 23949641 Free PMC article.

7

ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells.

Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP. Ignatoski KM, et al. Br J Cancer. 2000 Feb;82(3):666-74. doi: 10.1054/bjoc.1999.0979. Br J Cancer. 2000. PMID: 10682681 Free PMC article.

8

Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.

Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, Livant DL. Jia Y, et al. Among authors: ignatoski km. Cancer Res. 2004 Dec 1;64(23):8674-81. doi: 10.1158/0008-5472.CAN-04-0069. Cancer Res. 2004. PMID: 15574776

9

Constitutive activation of pp125fak in newly isolated human breast cancer cell lines.

Ignatoski KM, Ethier SP. Ignatoski KM, et al. Breast Cancer Res Treat. 1999 Mar;54(2):173-82. doi: 10.1023/a:1006135331912. Breast Cancer Res Treat. 1999. PMID: 10424408 Free article.

10

erbB-2 overexpression in human mammary epithelial cells confers growth factor independence.

Ignatoski KM, Lapointe AJ, Radany EH, Ethier SP. Ignatoski KM, et al. Endocrinology. 1999 Aug;140(8):3615-22. doi: 10.1210/endo.140.8.6939. Endocrinology. 1999. PMID: 10433219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters